Semaglutide, the drug found in Ozempic and Wegovy, was linked to nearly 40% fewer asthma attacks in a large real-world study. It was also associated with about 20% fewer COPD flare-ups. Researchers say GLP-1 drugs may offer respiratory benefits in addition to their effects on diabetes and obesity, but clinical trials are needed to confirm the findings.
More in Research
Venus’s pale yellow clouds may hide something surprisingly dark
September 13, 2026
Scientists find water was fueling volcanoes 3 billion years ago
September 13, 2026
A hidden compound in healthy foods may worsen IBD
September 13, 2026
Ozempic and Wegovy may raise hair loss risk in some men
September 13, 2026
Scientists discover a hidden switch that shuts down inflammation
September 13, 2026
CERN finds gluons behaving strangely deep inside atomic nuclei
September 12, 2026
Latest News
Antonelli wins as Norris loses out under virtual safety car
September 13, 2026
Boks power & All Blacks of old – what did we learn from series?
September 13, 2026
'I loved it' – Andy Burnham completes Great North Run
September 13, 2026
Struggling Preston North End sack Heckingbottom
September 13, 2026
Marquez moves top with MotoGP win in San Marino
September 13, 2026
Ronaldo demands lifetime bans over Jota chants
September 13, 2026